UFP Technologies Inc(UFPT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 32.18 | EPS (ttm) | 9.28 | Insider Own | 3.89% | Shs Outstand | 7.8M | Perf Week | 8.38% |
| Market Cap | 2.31B | Forward P/E | 27.51 | EPS next Y | 11.37% | Insider Trans | -12.77% | Shs Float | 7.4M | Perf Month | -1.88% |
| Enterprise Value | 2.44B | PEG | 2.05 | EPS next Q | 2.48 | Inst Own | 124.22% | Short Float | 14.16% | Perf Quarter | 18.1% |
| Income | 0.07B | P/S | 3.66 | EPS this Y | 11.34% | Inst Trans | 12.17% | Short Ratio | 6.06 | Perf Half Y | 57.04% |
| Sales | 0.63B | P/B | 5 | EPS next 5Y | 13.43% | ROA | 10.98% | Short Interest | 1.05M | Perf YTD | 34.43% |
| Book/sh | 59.7 | P/C | 255.75 | EPS past 3/5Y | 17.09% 37.73% | ROE | 17.05% | 52W High | -11.88% ($338.71) | Perf Year | 54.36% |
| Cash/sh | 1.17 | P/FCF | 37.64 | Sales past 3/5Y | 19.44% 27.43% | ROIC | 12.43% | 52W Low | 71.68% ($173.86) | Perf 3Y | 90.22% |
| Dividend Est. | - | EV/EBITDA | 21.05 | EPS Y/Y TTM | 7.24% | Gross Margin | 28.5% | Volatility(W/M) | 2.7% 2.69% | Perf 5Y | 379.79% |
| Dividend TTM | - | EV/Sales | 3.86 | Sales Y/Y TTM | 7.32% | Oper. Margin | 15.23% | ATR (14) | 8.89 | Perf 10Y | 1012.07% |
| Dividend Ex-Date | - | Quick Ratio | 1.72 | EPS Q/Q | 21.13% | Profit Margin | 11.45% | RSI (14) | 60.85 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3 | Sales Q/Q | 15.07% | SMA20 | 4.5% ($285.63) | Beta | 1.03 | Target Price | $355 |
| Payout | - | Debt/Eq | 0.29 | Earnings | 2026/8/4 | SMA50 | 4.21% ($286.42) | Rel Volume | 1.02 | Prev Close | $287.38 |
| Employees | 4846 | LT Debt/Eq | 0.26 | EPS/Sales Surpr. | 16.27% 9.15% | SMA200 | 23.7% ($241.29) | Avg Volume(3M) | 0.17M | Price | $298.48 |
| IPO | 1993/12/17 | Option/Short | Yes/Yes | Trades | 4554 | Volume | 177,545 | Change | 3.86% |
Company
UFPT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US medical device components company that manufactures custom parts and single-use products for medical devices. It manufactures and supplies custom-designed single-use medical components and packaging, specialty foam components, and more for medical device companies, and offers contract manufacturing solutions that integrate into customer medical device programs. It has established itself as a medical device components provider specializing in custom parts for medical devices.
Over the past 1 year, on the higher side
12% below its 1-year high.
UFPT makes money exceptionally well
15.23% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.3% this year.
Tap to view numbers
The price looks about right
Trading at 32.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +90.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 124.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $2B.
FAQ
What kind of company is UFPT?
UFPT belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of UFPT?
The market cap of UFPT is approximately $2.3B, ranking 1,966 within its sector.
What is the P/E ratio of UFPT?
UFPT has a P/E ratio of approximately 32.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for UFPT?
UFPT has recorded a 52-week high of $338.71 and a low of $173.86.